title: MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus.
abstract: A consensus panel was convened to review current knowledge of moisture-associated skin damage (MASD) and to provide recommendations for prevention and management. This article provides a summary of the discussion and the recommendations in regards to 2 types of MASD: incontinence-associated dermatitis (IAD) and intertriginous dermatitis (ITD). A focused history and physical assessment are essential for diagnosing IAD or ITD and distinguishing these forms of skin damage from other types of skin damage. Panel members recommend cleansing, moisturizing, and applying a skin protectant to skin affected by IAD and to the perineal skin of persons with urinary or fecal incontinence deemed at risk for IAD. Prevention and treatment of ITD includes measures to ensure that skin folds are dry and free from friction; however, panel members do not recommend use of bed linens, paper towels, or dressings for separating skin folds. Individuals with ITD are at risk for fungal and bacterial infections and these infections should be treated appropriately; for example, candidal infections should be treated with antifungal therapies.
authors: College of Nursing, University of Nebraska Medical Center, Omaha, NE, USA. jblack@unmc.edu
authors: Joyce M
authors: JM
authors: Black
authors: Mikel
authors: M
authors: Gray
authors: Donna Z
authors: DZ
authors: Bliss
authors: Karen L
authors: KL
authors: Kennedy-Evans
authors: Susan
authors: S
authors: Logan
authors: Mona M
authors: MM
authors: Baharestani
authors: Janice C
authors: JC
authors: Colwell
authors: Margaret
authors: M
authors: Goldberg
authors: Catherine R
authors: CR
authors: Ratliff
mesh_terms: D003131:Combined Modality Therapy; D017453:Dermatitis, Irritant / Q000209:etiology* / Q000451:nursing / Q000628:therapy*; D005242:Fecal Incontinence / Q000150:complications*; D005260:Female; D006801:Humans; D009730:Nursing Assessment; D017592:Skin Care / Q000379:methods*; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000150:complications*; D014867:Water / Q000009:adverse effects
chemical_list: D014867:Water